Evidence map›Paper›PMID 38339066›Full record

ArticleInternational journal of molecular sciences2024

Clinical Characteristics and Local Histopathological Modulators of Endometriosis and Its Progression.

Anca-Maria Istrate-Ofiţeru, Carmen Aurelia Mogoantă, George-Lucian Zorilă, Gabriela-Camelia Roşu, Roxana Cristina Drăguşin, Elena-Iuliana-Anamaria Berbecaru, Marian Valentin Zorilă, Cristina Maria Comănescu, Stelian-Ștefăniță Mogoantă, Constantin-Cristian Vaduva and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Induction of Endometriosis in a Menstruating Mouse Model (Mus musculus): A Translational Animal Disease Model.Journal of the American Association for Laboratory Animal Science : JAALAS · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Kisspeptin and Endometriosis-Is There a Link?Journal of clinical medicine · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Clinical efficacy study of the IBSWorld journal of surgical oncology · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Anca-Maria Istrate-OfiţeruDepartment of Histology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0002-3631-9107
Carmen Aurelia MogoantăENT Department, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
George-Lucian ZorilăDepartment of Obstetrics and Gynecology, University Emergency County Hospital, 200642 Craiova, Romania.ORCID 0000-0002-2358-7866
Gabriela-Camelia RoşuDepartment of Histology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Roxana Cristina DrăguşinDepartment of Obstetrics and Gynecology, University Emergency County Hospital, 200642 Craiova, Romania.ORCID 0000-0001-6815-4581
Elena-Iuliana-Anamaria BerbecaruDoctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Marian Valentin ZorilăDepartment of Forensic Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Cristina Maria ComănescuDepartment of Anatomy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Stelian-Ștefăniță MogoantăGeneral Surgery Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Constantin-Cristian VaduvaDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0001-7526-1756
Elvira BrătilăDepartment of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Dominic Gabriel IliescuDepartment of Obstetrics and Gynecology, University Emergency County Hospital, 200642 Craiova, Romania.ORCID 0000-0002-7823-3387
University of Medicine and Pharmacy of Craiova · ROCarol Davila University of Medicine and Pharmacy · RO

Funding

University of Medicine and Pharmacy of Craiova 26/531/14 from 31 May 2022
6 · The paper itself

Abstract

Endometriosis (E) and adenomyosis (A) are associated with a wide spectrum of symptoms and may present various histopathological transformations, such as the presence of hyperplasia, atypia, and malignant transformation occurring under the influence of local inflammatory, vascular and hormonal factors and by the alteration of tumor suppressor proteins and the inhibition of cell apoptosis, with an increased degree of lesion proliferation. MATERIAL AND

methodsThis retrospective study included 243 patients from whom tissue with E/A or normal control uterine tissue was harvested and stained by histochemical and classical immunohistochemical staining. We assessed the symptomatology of the patients, the structure of the ectopic epithelium and the presence of neovascularization, hormone receptors, inflammatory cells and oncoproteins involved in lesion development. Atypical areas were analyzed using multiple immunolabeling techniques.

resultsThe cytokeratin (CK) CK7+/CK20- expression profile was present in E foci and differentiated them from digestive metastases. The neovascularization marker cluster of differentiation (CD) 34+ was increased, especially in areas with malignant transformation of E or A foci. T:CD3+ lymphocytes, B:CD20+ lymphocytes, CD68+ macrophages and tryptase+ mast cells were abundant, especially in cases associated with malignant transformation, being markers of the proinflammatory microenvironment. In addition, we found a significantly increased cell division index (Ki67+), with transformation and inactivation of tumor suppressor genes p53, B-cell lymphoma 2 (BCL-2) and Phosphatase and tensin homolog (PTEN) in areas with E/A-transformed malignancy.

conclusionsProinflammatory/vascular/hormonal changes trigger E/A progression and the onset of cellular atypia and malignant transformation, exacerbating symptoms, especially local pain and vaginal bleeding. These triggers may represent future therapeutic targets.

Indexed as

AdenomyosisEndometriosisEpitheliumFemaleHumansRetrospective StudiesTumor Suppressor Protein p53Tumor Suppressor Protein p53adenomyosisendometriosismultiple immunohistochemistry

Identifiers

PMID38339066
PMCPMC10855449
OpenAlexW4391433966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.